Report Detail

Pharma & Healthcare Global (United States, European Union and China) Orlistat Market Research Report 2019-2025

  • RnM3352334
  • |
  • 03 July, 2020
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Orlistat market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Orlistat market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Orlistat market is segmented into
120mg
60mg

Segment by Application, the Orlistat market is segmented into
Weight-reducing Aid
Other

Regional and Country-level Analysis
The Orlistat market is analysed and market size information is provided by regions (countries).
The key regions covered in the Orlistat market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Orlistat Market Share Analysis
Orlistat market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Orlistat business, the date to enter into the Orlistat market, Orlistat product introduction, recent developments, etc.

The major vendors covered:
Roche
GSK group
Teva
Sandoz(Novartis)
STADA-VN J.V.Co., Ltd
Hexal AG
National Company for Pharmaceutical Industry
Lunan Pharmaceutical Group Corporation
ZEIN pharmaceutical
HISUN
Taj Pharmaceuticals Ltd
Kabir Life Sciences & Research
DM Pharma
China Zhongshan Pharm


1 Study Coverage

  • 1.1 Orlistat Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Orlistat Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Orlistat Market Size Growth Rate by Type
    • 1.4.2 120mg
    • 1.4.3 60mg
  • 1.5 Market by Application
    • 1.5.1 Global Orlistat Market Size Growth Rate by Application
    • 1.5.2 Weight-reducing Aid
    • 1.5.3 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Orlistat Market Size, Estimates and Forecasts
    • 2.1.1 Global Orlistat Revenue 2015-2026
    • 2.1.2 Global Orlistat Sales 2015-2026
  • 2.2 Global Orlistat, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Orlistat Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Orlistat Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Orlistat Competitor Landscape by Players

  • 3.1 Orlistat Sales by Manufacturers
    • 3.1.1 Orlistat Sales by Manufacturers (2015-2020)
    • 3.1.2 Orlistat Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Orlistat Revenue by Manufacturers
    • 3.2.1 Orlistat Revenue by Manufacturers (2015-2020)
    • 3.2.2 Orlistat Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Orlistat Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Orlistat Revenue in 2019
    • 3.2.5 Global Orlistat Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Orlistat Price by Manufacturers
  • 3.4 Orlistat Manufacturing Base Distribution, Product Types
    • 3.4.1 Orlistat Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Orlistat Product Type
    • 3.4.3 Date of International Manufacturers Enter into Orlistat Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Orlistat Market Size by Type (2015-2020)
    • 4.1.1 Global Orlistat Sales by Type (2015-2020)
    • 4.1.2 Global Orlistat Revenue by Type (2015-2020)
    • 4.1.3 Orlistat Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Orlistat Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Orlistat Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Orlistat Revenue Forecast by Type (2021-2026)
    • 4.2.3 Orlistat Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Orlistat Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Orlistat Market Size by Application (2015-2020)
    • 5.1.1 Global Orlistat Sales by Application (2015-2020)
    • 5.1.2 Global Orlistat Revenue by Application (2015-2020)
    • 5.1.3 Orlistat Price by Application (2015-2020)
  • 5.2 Orlistat Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Orlistat Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Orlistat Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Orlistat Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Orlistat by Country
    • 6.1.1 North America Orlistat Sales by Country
    • 6.1.2 North America Orlistat Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Orlistat Market Facts & Figures by Type
  • 6.3 North America Orlistat Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Orlistat by Country
    • 7.1.1 Europe Orlistat Sales by Country
    • 7.1.2 Europe Orlistat Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Orlistat Market Facts & Figures by Type
  • 7.3 Europe Orlistat Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Orlistat by Region
    • 8.1.1 Asia Pacific Orlistat Sales by Region
    • 8.1.2 Asia Pacific Orlistat Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Orlistat Market Facts & Figures by Type
  • 8.3 Asia Pacific Orlistat Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Orlistat by Country
    • 9.1.1 Latin America Orlistat Sales by Country
    • 9.1.2 Latin America Orlistat Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Orlistat Market Facts & Figures by Type
  • 9.3 Central & South America Orlistat Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Orlistat by Country
    • 10.1.1 Middle East and Africa Orlistat Sales by Country
    • 10.1.2 Middle East and Africa Orlistat Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Orlistat Market Facts & Figures by Type
  • 10.3 Middle East and Africa Orlistat Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Roche
    • 11.1.1 Roche Corporation Information
    • 11.1.2 Roche Description and Business Overview
    • 11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Roche Orlistat Products Offered
    • 11.1.5 Roche Related Developments
  • 11.2 GSK group
    • 11.2.1 GSK group Corporation Information
    • 11.2.2 GSK group Description and Business Overview
    • 11.2.3 GSK group Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 GSK group Orlistat Products Offered
    • 11.2.5 GSK group Related Developments
  • 11.3 Teva
    • 11.3.1 Teva Corporation Information
    • 11.3.2 Teva Description and Business Overview
    • 11.3.3 Teva Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Teva Orlistat Products Offered
    • 11.3.5 Teva Related Developments
  • 11.4 Sandoz(Novartis)
    • 11.4.1 Sandoz(Novartis) Corporation Information
    • 11.4.2 Sandoz(Novartis) Description and Business Overview
    • 11.4.3 Sandoz(Novartis) Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Sandoz(Novartis) Orlistat Products Offered
    • 11.4.5 Sandoz(Novartis) Related Developments
  • 11.5 STADA-VN J.V.Co., Ltd
    • 11.5.1 STADA-VN J.V.Co., Ltd Corporation Information
    • 11.5.2 STADA-VN J.V.Co., Ltd Description and Business Overview
    • 11.5.3 STADA-VN J.V.Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 STADA-VN J.V.Co., Ltd Orlistat Products Offered
    • 11.5.5 STADA-VN J.V.Co., Ltd Related Developments
  • 11.6 Hexal AG
    • 11.6.1 Hexal AG Corporation Information
    • 11.6.2 Hexal AG Description and Business Overview
    • 11.6.3 Hexal AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Hexal AG Orlistat Products Offered
    • 11.6.5 Hexal AG Related Developments
  • 11.7 National Company for Pharmaceutical Industry
    • 11.7.1 National Company for Pharmaceutical Industry Corporation Information
    • 11.7.2 National Company for Pharmaceutical Industry Description and Business Overview
    • 11.7.3 National Company for Pharmaceutical Industry Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 National Company for Pharmaceutical Industry Orlistat Products Offered
    • 11.7.5 National Company for Pharmaceutical Industry Related Developments
  • 11.8 Lunan Pharmaceutical Group Corporation
    • 11.8.1 Lunan Pharmaceutical Group Corporation Corporation Information
    • 11.8.2 Lunan Pharmaceutical Group Corporation Description and Business Overview
    • 11.8.3 Lunan Pharmaceutical Group Corporation Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Lunan Pharmaceutical Group Corporation Orlistat Products Offered
    • 11.8.5 Lunan Pharmaceutical Group Corporation Related Developments
  • 11.9 ZEIN pharmaceutical
    • 11.9.1 ZEIN pharmaceutical Corporation Information
    • 11.9.2 ZEIN pharmaceutical Description and Business Overview
    • 11.9.3 ZEIN pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 ZEIN pharmaceutical Orlistat Products Offered
    • 11.9.5 ZEIN pharmaceutical Related Developments
  • 11.10 HISUN
    • 11.10.1 HISUN Corporation Information
    • 11.10.2 HISUN Description and Business Overview
    • 11.10.3 HISUN Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 HISUN Orlistat Products Offered
    • 11.10.5 HISUN Related Developments
  • 11.1 Roche
    • 11.1.1 Roche Corporation Information
    • 11.1.2 Roche Description and Business Overview
    • 11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Roche Orlistat Products Offered
    • 11.1.5 Roche Related Developments
  • 11.12 Kabir Life Sciences & Research
    • 11.12.1 Kabir Life Sciences & Research Corporation Information
    • 11.12.2 Kabir Life Sciences & Research Description and Business Overview
    • 11.12.3 Kabir Life Sciences & Research Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Kabir Life Sciences & Research Products Offered
    • 11.12.5 Kabir Life Sciences & Research Related Developments
  • 11.13 DM Pharma
    • 11.13.1 DM Pharma Corporation Information
    • 11.13.2 DM Pharma Description and Business Overview
    • 11.13.3 DM Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 DM Pharma Products Offered
    • 11.13.5 DM Pharma Related Developments
  • 11.14 China Zhongshan Pharm
    • 11.14.1 China Zhongshan Pharm Corporation Information
    • 11.14.2 China Zhongshan Pharm Description and Business Overview
    • 11.14.3 China Zhongshan Pharm Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 China Zhongshan Pharm Products Offered
    • 11.14.5 China Zhongshan Pharm Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Orlistat Market Estimates and Projections by Region
    • 12.1.1 Global Orlistat Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Orlistat Revenue Forecast by Regions 2021-2026
  • 12.2 North America Orlistat Market Size Forecast (2021-2026)
    • 12.2.1 North America: Orlistat Sales Forecast (2021-2026)
    • 12.2.2 North America: Orlistat Revenue Forecast (2021-2026)
    • 12.2.3 North America: Orlistat Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Orlistat Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Orlistat Sales Forecast (2021-2026)
    • 12.3.2 Europe: Orlistat Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Orlistat Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Orlistat Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Orlistat Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Orlistat Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Orlistat Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Orlistat Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Orlistat Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Orlistat Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Orlistat Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Orlistat Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Orlistat Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Orlistat Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Orlistat Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Orlistat Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Orlistat Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Orlistat . Industry analysis & Market Report on Orlistat is a syndicated market report, published as Global (United States, European Union and China) Orlistat Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Orlistat market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,104.40
    4,656.60
    6,208.80
    3,623.10
    5,434.65
    7,246.20
    600,366.00
    900,549.00
    1,200,732.00
    325,689.00
    488,533.50
    651,378.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report